1.04509588754673E-05 -0.000156764383132129 -2.09019177509346E-05 -0.00174531013220459 -0.00111825259967607 -0.00111825259967607 -0.00111825259967607 -0.00111825259967607
Sign Up Today X
Thanks for submitting the form.
Stockreport

Three decades into cystic fibrosis fight, Boomer Esiason and his son Gunnar are winning [CNBC]

Vertex Pharmaceuticals Incorporated (VRTX)  More Company Research Source: CNBC
Last vertex pharmaceuticals incorporated earnings: 4/29 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.vrtx.com
fibrosis, then a little-known disease that was viewed as a fatal pediatric disease at the time. In the years since, the Esiason family has become one of the biggest advocates for awareness, research and the push for a cure for CF, raising nearly $200 million via the Boomer Esiason Foundation. Boomer and Gunnar Esiason joined CNBC's Becky Quick at the CNBC Cares Summit to discuss that journey on Tuesday. As NFL quarterback Boomer Esiason was about to step onto the practice field for the New York Jets in 1993, shortly after being traded to the team, he was quickly pulled off to take an urgent phone call from his wife, Cheryl. Their two-year-old son, Gunnar, had been rushed to Cincinnati Children's Hospital. Shortly thereafter, Gunnar was diagnosed with cystic fibrosis, an inherited genetic disorder that causes mucus to build up and damage organs in the body, particularly the lungs, and often leads to permanent lung damage. Symptoms of the disease can appear at any age, but at th [Read more]
IMPACT SNAPSHOT EVENT TIME: VRTX
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
VRTX alerts
from News Quantified
VRTX
NEWS
VRTX
Earnings
VRTX
Analyst Actions
VRTX
SEC Filings
Stockreport

Three decades into cystic fibrosis fight, Boomer Esiason and his son Gunnar are winning [CNBC]

Vertex Pharmaceuticals Incorporated  (VRTX) 
More Company Research Source: CNBC
Last vertex pharmaceuticals incorporated earnings: 4/29 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.vrtx.com
fibrosis, then a little-known disease that was viewed as a fatal pediatric disease at the time. In the years since, the Esiason family has become one of the biggest advocates for awareness, research and the push for a cure for CF, raising nearly $200 million via the Boomer Esiason Foundation. Boomer and Gunnar Esiason joined CNBC's Becky Quick at the CNBC Cares Summit to discuss that journey on Tuesday. As NFL quarterback Boomer Esiason was about to step onto the practice field for the New York Jets in 1993, shortly after being traded to the team, he was quickly pulled off to take an urgent phone call from his wife, Cheryl. Their two-year-old son, Gunnar, had been rushed to Cincinnati Children's Hospital. Shortly thereafter, Gunnar was diagnosed with cystic fibrosis, an inherited genetic disorder that causes mucus to build up and damage organs in the body, particularly the lungs, and often leads to permanent lung damage. Symptoms of the disease can appear at any age, but at th [Read more]
IMPACT SNAPSHOT
EVENT TIME:
VRTX
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Don't Miss Out On The Next BIG Stock Move
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS